Christophe Arbet-Engels

Insider Reports History

Entity
Individual
Location
C/O Millendo Therapeutics, Inc., 110 Miller Avenue, Suite 100, Ann Arbor, MI
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christophe Arbet-Engels:

Stock Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Medical Officer Stock Option (right to buy) 1.25M Aug 31, 2023 Direct
X4 Pharmaceuticals, Inc Chief Medical Officer Stock Appreciation Right 181K Feb 13, 2024 Direct

Insider Reports Filed by Christophe Arbet-Engels

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XFOR X4 Pharmaceuticals, Inc Feb 13, 2024 1 $0 4/A Feb 28, 2024 Chief Medical Officer
XFOR X4 Pharmaceuticals, Inc Feb 13, 2024 1 $0 4 Feb 16, 2024 Chief Medical Officer
XFOR X4 Pharmaceuticals, Inc Aug 31, 2023 1 $1.6M 4 Sep 5, 2023 Chief Medical Officer
XFOR X4 Pharmaceuticals, Inc Aug 16, 2023 0 $0 3 Aug 16, 2023 Chief Medical Officer